JPWO2022250015A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022250015A5 JPWO2022250015A5 JP2023523467A JP2023523467A JPWO2022250015A5 JP WO2022250015 A5 JPWO2022250015 A5 JP WO2022250015A5 JP 2023523467 A JP2023523467 A JP 2023523467A JP 2023523467 A JP2023523467 A JP 2023523467A JP WO2022250015 A5 JPWO2022250015 A5 JP WO2022250015A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment agent
- liposome
- agent according
- topotecan
- aqueous phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163192329P | 2021-05-24 | 2021-05-24 | |
| PCT/JP2022/021106 WO2022250015A1 (ja) | 2021-05-24 | 2022-05-23 | 処置剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022250015A1 JPWO2022250015A1 (https=) | 2022-12-01 |
| JPWO2022250015A5 true JPWO2022250015A5 (https=) | 2024-02-26 |
Family
ID=84228811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023523467A Pending JPWO2022250015A1 (https=) | 2021-05-24 | 2022-05-23 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240099974A1 (https=) |
| EP (1) | EP4349338A4 (https=) |
| JP (1) | JPWO2022250015A1 (https=) |
| CN (1) | CN117355301A (https=) |
| TW (1) | TW202313032A (https=) |
| WO (1) | WO2022250015A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100679906B1 (ko) | 1998-09-16 | 2007-02-07 | 알자 코포레이션 | 리포솜-엔트랩된 토포이소머라제 억제제 |
| JP2004501955A (ja) | 2000-06-30 | 2004-01-22 | アイネックス ファーマシューティカルズ コーポレイション | リポソーム抗新生物薬剤およびその使用 |
| EP1750673B1 (en) | 2004-05-17 | 2009-12-02 | Tekmira Pharmaceuticals Corporation | Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof |
| US20090285878A1 (en) | 2004-11-05 | 2009-11-19 | Tekmira Pharmaceuticals Corporation | Compositions and methods for stabilizing liposomal drug formulations |
| JP2010518140A (ja) * | 2007-02-14 | 2010-05-27 | グラクソ グループ リミテッド | Ｉｇｆ−１ｒに対する新規抗体 |
| RU2734900C1 (ru) | 2017-03-31 | 2020-10-26 | Фуджифилм Корпорэйшн | Липосомальная композиция и фармацевтическая композиция |
| TWI837189B (zh) * | 2018-10-01 | 2024-04-01 | 日商富士軟片股份有限公司 | 包含內含藥物之脂質體組成物及鉑製劑之組合醫藥 |
-
2022
- 2022-05-23 TW TW111119107A patent/TW202313032A/zh unknown
- 2022-05-23 CN CN202280036277.2A patent/CN117355301A/zh active Pending
- 2022-05-23 WO PCT/JP2022/021106 patent/WO2022250015A1/ja not_active Ceased
- 2022-05-23 JP JP2023523467A patent/JPWO2022250015A1/ja active Pending
- 2022-05-23 EP EP22811285.0A patent/EP4349338A4/en active Pending
-
2023
- 2023-11-21 US US18/516,010 patent/US20240099974A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yingchoncharoen et al. | Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come | |
| ES2704986T3 (es) | Combinaciones de una camptotecina liposomal soluble en agua con cetuximab o bevacizumab | |
| US6207133B1 (en) | Anti-tumoral therapy agent containing a contrast agent | |
| ES2703505T3 (es) | Combinación de adapaleno y peróxido de benzoilo para tratar lesiones de acné | |
| US20140303329A1 (en) | Method of manufacturing a pharmaceutical composition having chelating type complex micelles | |
| US20050238705A1 (en) | Lipid-based dispersions useful for drug delivery | |
| JP2002521428A5 (https=) | ||
| ES2777223T3 (es) | Composición de liposoma para liberación controlada de fármaco | |
| EP2783679A1 (en) | Drug carrier with chelating composite micell and use thereof | |
| FI3821887T3 (fi) | Mitoksantroni liposomin käyttö ei-hodgkinin lymfooman hoitoon | |
| JP2005538093A5 (https=) | ||
| JP2025509507A5 (https=) | ||
| JPWO2022250015A5 (https=) | ||
| JPWO2022250013A5 (https=) | ||
| ES2347119B2 (es) | Nanocapsulas de poliarginina. | |
| CN103327975A (zh) | 用于治疗多形性成胶质母细胞瘤的含有马西替坦的组合物 | |
| CN101283987A (zh) | 氯喹脂质体冻干粉针及制备方法 | |
| ES2276973T3 (es) | Liposomas que contienen (ester) lisolecitina. | |
| SI2847204T1 (en) | Sterol derivatives and their use for the treatment of diseases involving the transformation of astrocytic cells or the treatment of malignant haemopathies | |
| JP2017514831A5 (https=) | ||
| CN110013553B (zh) | 通过具有蛋白质表达于其表面的囊泡递送药剂至自噬及凋亡细胞 | |
| ES2699711T3 (es) | Composiciones farmacéuticas encapsuladas en gelatina blanda que comprenden ingredientes activos concentrados | |
| US9326989B2 (en) | Oleyl phosphocholine | |
| US20160271072A1 (en) | Polymer nanoparticles containing multiple agents and methods thereof | |
| RU2015117412A (ru) | Улучшенный способ получения инкапсулированного в липосомы винкристина для терапевтического применения |